Eli Lilly Urges Justices To Rethink Patent-Eligibility Test
Eli Lilly & Co. and others have urged the U.S. Supreme Court to reconsider its precedent regarding patent-eligibility, saying in an amicus brief in a high-profile case over Sequenom's DNA test...To view the full article, register now.
Already a subscriber? Click here to view full article